Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 23 Feb 2023

Establishment and application of a high-throughput screening model for cell adhesion inhibitors

in Inflammation Pharmacology

Han Sun
Xue-Kai Wang
Jian-Rui Li
Mei Tang
Hu Li
Lei Lei
Hong-Ying Li
Jing Jiang
Jia-Yu Li
Biao Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1140163

3,044 views
4 citations

Review

Published on 21 Feb 2023

Trained immunity in monocyte/macrophage: Novel mechanism of phytochemicals in the treatment of atherosclerotic cardiovascular disease

in Inflammation Pharmacology

Jie Wang
Yong-Mei Liu
Jun Hu
Cong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1109576

9,439 views
7 citations

Original Research

Published on 20 Feb 2023

Protective effect of bioactive iridium nanozymes on high altitude-related hypoxia-induced kidney injury in mice

in Inflammation Pharmacology

Yujing Wang
Meijun Shi
Zongtang Chu
Xinlin Yan
Guoxing You
Gan Chen
Hong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1115224

3,153 views
5 citations

Review

Published on 16 Feb 2023

Natural products can modulate inflammation in intervertebral disc degeneration

in Inflammation Pharmacology

Zongtai Liu
Jiabo Zhu
Haiyan Liu
Changfeng Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1150835

4,796 views
7 citations

Editorial

Published on 16 Feb 2023

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases

in Inflammation Pharmacology

Yongyi Liang
Zhenyi Su
Xiaoyuan Mao
Shibiao Wan
Lianxiang Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1152326

2,036 views

Clinical Trial

Published on 16 Feb 2023

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients

in Inflammation Pharmacology

Jing Wang
Bomiao Ju
Li Zhu
Hanchao Li
Jing Luo
Jing Zhang
Nan Hu
Lingfei Mo
Yanhua Wang
Ying Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1080730

3,916 views
3 citations

Original Research

Published on 15 Feb 2023

Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro

in Inflammation Pharmacology

Dequan Zeng
Lipen Zhang
Qiang Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1124240

4,823 views
13 citations

Original Research

Published on 15 Feb 2023

Dietary methionine restriction alleviates oxidative stress and inflammatory responses in lipopolysaccharide-challenged broilers at early age

in Inflammation Pharmacology

Xiyuan Pang
Zhiqiang Miao
Yuanyang Dong
Huiyu Cheng
Xiangqi Xin
Yuan Wu
Miaomiao Han
Yuan Su
Jianmin Yuan
Yuxin Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1120718

3,374 views
9 citations

Review

Published on 15 Feb 2023

TRPV1: A promising therapeutic target for skin aging and inflammatory skin diseases

in Inflammation Pharmacology

Tengfei Xiao
Mingzhong Sun
Chuanxiang Zhao
Jingjing Kang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1037925

17,985 views
42 citations

Systematic Review

Published on 14 Feb 2023

Systematic review with meta-analysis: Efficacy and safety of biological treatment on salivary gland function in primary Sjögren’s syndrome

in Inflammation Pharmacology

Xiaoyan Wang
Xiang Lin
Yingying Su
Hao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1093924

3,723 views
5 citations

Review

Published on 14 Feb 2023

Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies

in Inflammation Pharmacology

Braden Millar
Monica de Gaetano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1125858

5,267 views
2 citations

Original Research

Published on 13 Feb 2023

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients

in Inflammation Pharmacology

Lin Cheng
Zaiming Liang
Fang Liu
Ling Lin
Jiao Zhang
Linli Xie
Mingjie Yu
Fengjun Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1126580

2,180 views
5 citations

Systematic Review

Published on 13 Feb 2023

Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials

in Inflammation Pharmacology

Haihuan Feng
Ying Zhao
Weihong Kuang
Yanping Dai
Xiaobo Cen
Feng Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1084614

4,134 views
7 citations

Editorial

Published on 09 Feb 2023

Editorial: Leukocyte biology and muscle pathology: Leukocytes as potential targets to control muscle inflammation, mass, and pain

in Inflammation Pharmacology

Miriam S. N. Hohmann
Waldiceu A. Verri
Flavia A. Guarnier
Barbara St. Pierre Schneider
Sergio M. Borghi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154559

1,336 views

Review

Published on 07 Feb 2023

Advances in the mechanisms and applications of inhibitory oligodeoxynucleotides against immune-mediated inflammatory diseases

in Inflammation Pharmacology

Hongrui Wang
Yingying Su
Duoduo Chen
Qi Li
Shuyou Shi
Xin Huang
Mingli Fang
Ming Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119431

2,958 views
5 citations

Editorial

Published on 02 Feb 2023

Editorial: Acute phase proteins as biomarkers and therapeutics in acute and chronic inflammatory conditions

in Inflammation Pharmacology

Frauke Stanke
Sabina Janciauskiene
Beata Olejnicka

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1145990

1,511 views